Prosight Management as of Sept. 30, 2022
Portfolio Holdings for Prosight Management
Prosight Management holds 38 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prothena Corp SHS (PRTA) | 10.4 | $20M | 321k | 60.63 | |
Horizon Therapeutics Pub L SHS | 10.0 | $19M | 303k | 61.89 | |
Galapagos Nv Spon Adr (GLPG) | 9.3 | $17M | 405k | 42.64 | |
Kezar Life Sciences (KZR) | 6.1 | $11M | 1.3M | 8.61 | |
Alkermes SHS (ALKS) | 6.0 | $11M | 502k | 22.33 | |
Albireo Pharma | 5.1 | $9.5M | 491k | 19.36 | |
Meiragtx Holdings (MGTX) | 5.0 | $9.3M | 1.1M | 8.41 | |
Kalvista Pharmaceuticals (KALV) | 4.1 | $7.7M | 530k | 14.51 | |
Charles River Laboratories (CRL) | 3.5 | $6.5M | 33k | 196.81 | |
Aldeyra Therapeutics (ALDX) | 3.5 | $6.5M | 1.2M | 5.34 | |
Humana (HUM) | 3.3 | $6.2M | 13k | 485.16 | |
Mirum Pharmaceuticals (MIRM) | 3.2 | $6.0M | 285k | 21.01 | |
Tenet Healthcare Corp Com New (THC) | 2.8 | $5.3M | 102k | 51.58 | |
Johnson & Johnson (JNJ) | 2.8 | $5.2M | 32k | 163.35 | |
Quidel Corp (QDEL) | 2.4 | $4.5M | 63k | 71.48 | |
Cue Biopharma (CUE) | 1.8 | $3.4M | 1.5M | 2.23 | |
Prothena Corp Call Call Option | 1.7 | $3.2M | 53k | 60.62 | |
Rocket Pharmaceuticals (RCKT) | 1.7 | $3.2M | 200k | 15.96 | |
Shattuck Labs (STTK) | 1.6 | $3.0M | 1.1M | 2.70 | |
Oric Pharmaceuticals (ORIC) | 1.6 | $3.0M | 936k | 3.20 | |
Incyte Corporation (INCY) | 1.4 | $2.7M | 41k | 66.65 | |
Omnicell (OMCL) | 1.4 | $2.7M | 31k | 87.04 | |
Avantor (AVTR) | 1.3 | $2.4M | 123k | 19.60 | |
Baxter International (BAX) | 1.1 | $2.1M | 39k | 53.87 | |
Rhythm Pharmaceuticals (RYTM) | 1.1 | $2.0M | 80k | 24.50 | |
1life Healthcare | 1.0 | $1.8M | 106k | 17.15 | |
Cassava Sciences Put Put Option | 0.8 | $1.5M | 36k | 41.81 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $1.4M | 114k | 12.60 | |
Ardelyx (ARDX) | 0.7 | $1.3M | 1.1M | 1.19 | |
Evolus (EOLS) | 0.7 | $1.3M | 160k | 8.05 | |
Proqr Thrapeutics N V Shs Euro (PRQR) | 0.7 | $1.3M | 1.7M | 0.74 | |
Adc Therapeutics Sa SHS (ADCT) | 0.6 | $1.2M | 248k | 4.82 | |
Graphite Bio | 0.6 | $1.1M | 356k | 3.17 | |
Silverback Therapeutics (SPRY) | 0.6 | $1.0M | 196k | 5.28 | |
Abcellera Biologics (ABCL) | 0.5 | $856k | 87k | 9.90 | |
R1 RCM (RCM) | 0.3 | $595k | 32k | 18.53 | |
Spok Holdings (SPOK) | 0.3 | $497k | 65k | 7.65 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.1 | $218k | 8.5k | 25.53 |